⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for abelacimab

Every month we try and update this database with for abelacimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTENCT05171075
Venous Thromboe...
Deep Venous Thr...
Pulmonary Embol...
Abelacimab
Dalteparin
18 Years - Anthos Therapeutics, Inc.
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049
Venous Thromboe...
Deep Venous Thr...
Pulmonary Embol...
Abelacimab
Apixaban
18 Years - Anthos Therapeutics, Inc.
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049
Venous Thromboe...
Deep Venous Thr...
Pulmonary Embol...
Abelacimab
Apixaban
18 Years - Anthos Therapeutics, Inc.
A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTENCT05171075
Venous Thromboe...
Deep Venous Thr...
Pulmonary Embol...
Abelacimab
Dalteparin
18 Years - Anthos Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: